285 related articles for article (PubMed ID: 1710663)
1. Effects of agonist efficacy on desensitization of phosphoinositide hydrolysis mediated by m1 and m3 muscarinic receptors expressed in Chinese hamster ovary cells.
Hu J; Wang SZ; el-Fakahany EE
J Pharmacol Exp Ther; 1991 Jun; 257(3):938-45. PubMed ID: 1710663
[TBL] [Abstract][Full Text] [Related]
2. Selectivity of McN-A-343 in stimulating phosphoinositide hydrolysis mediated by M1 muscarinic receptors.
Hu JR; el-Fakahany EE
Mol Pharmacol; 1990 Dec; 38(6):895-903. PubMed ID: 1701216
[TBL] [Abstract][Full Text] [Related]
3. Application of transfected cell lines in studies of functional receptor subtype selectivity of muscarinic agonists.
Wang SZ; el-Fakahany EE
J Pharmacol Exp Ther; 1993 Jul; 266(1):237-43. PubMed ID: 7687290
[TBL] [Abstract][Full Text] [Related]
4. The putative M1 muscarinic receptor does not regulate phosphoinositide hydrolysis. Studies with pirenzepine and McN-A343 in chick heart and astrocytoma cells.
Brown JH; Goldstein D; Masters SB
Mol Pharmacol; 1985 May; 27(5):525-31. PubMed ID: 2581122
[TBL] [Abstract][Full Text] [Related]
5. Differential coupling of m1, m2 and m3 muscarinic receptor subtypes to inositol 1,4,5-trisphosphate and adenosine 3',5'-cyclic monophosphate accumulation in Chinese hamster ovary cells.
Burford NT; Tobin AB; Nahorski SR
J Pharmacol Exp Ther; 1995 Jul; 274(1):134-42. PubMed ID: 7616390
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic comparison of selected agonists for the M1 muscarinic receptor in transfected murine fibroblast cells (B82).
Mei L; Lai J; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1991 Feb; 256(2):689-94. PubMed ID: 1704434
[TBL] [Abstract][Full Text] [Related]
7. Cysteine pairs in the third intracellular loop of the muscarinic m1 acetylcholine receptor play a role in agonist-induced internalization.
Sawyer GW; Ehlert FJ; Shults CA
J Pharmacol Exp Ther; 2008 Jan; 324(1):196-205. PubMed ID: 17540859
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological basis for functional selectivity of partial muscarinic receptor agonists.
Heldman E; Barg J; Fisher A; Levy R; Pittel Z; Zimlichman R; Kushnir M; Vogel Z
Eur J Pharmacol; 1996 Feb; 297(3):283-91. PubMed ID: 8666061
[TBL] [Abstract][Full Text] [Related]
9. Rapid desensitization of muscarinic m3 receptor-stimulated polyphosphoinositide responses.
Tobin AB; Lambert DG; Nahorski SR
Mol Pharmacol; 1992 Dec; 42(6):1042-8. PubMed ID: 1480131
[TBL] [Abstract][Full Text] [Related]
10. Alanine scanning mutagenesis of conserved arginine/lysine-arginine/lysine-X-X-arginine/lysine G protein-activating motifs on m1 muscarinic acetylcholine receptors.
Lee NH; Geoghagen NS; Cheng E; Cline RT; Fraser CM
Mol Pharmacol; 1996 Jul; 50(1):140-8. PubMed ID: 8700106
[TBL] [Abstract][Full Text] [Related]
11. Mutation of carboxyl-terminal threonine residues in human m3 muscarinic acetylcholine receptor modulates the extent of sequestration and desensitization.
Yang J; Williams JA; Yule DI; Logsdon CD
Mol Pharmacol; 1995 Sep; 48(3):477-85. PubMed ID: 7565628
[TBL] [Abstract][Full Text] [Related]
12. Muscarinic acetylcholine receptor-mediated phosphoinositide turnover in cultured cerebellar granule cells: desensitization by receptor agonists.
Xu J; Chuang DM
J Pharmacol Exp Ther; 1987 Jul; 242(1):238-44. PubMed ID: 3039110
[TBL] [Abstract][Full Text] [Related]
13. Agonist-induced desensitization of muscarinic receptor-mediated calcium efflux without concomitant desensitization of phosphoinositide hydrolysis.
Masters SB; Quinn MT; Brown JH
Mol Pharmacol; 1985 Mar; 27(3):325-32. PubMed ID: 2983182
[TBL] [Abstract][Full Text] [Related]
14. Human m3 muscarinic acetylcholine receptor carboxyl-terminal threonine resides are required for agonist-induced receptor down-regulation.
Yang J; Logsdon CD; Johansen TE; Williams JA
Mol Pharmacol; 1993 Dec; 44(6):1158-64. PubMed ID: 8264552
[TBL] [Abstract][Full Text] [Related]
15. The interaction of the enantiomers of aceclidine with subtypes of the muscarinic receptor.
Ehlert FJ; Griffin MT; Glidden PF
J Pharmacol Exp Ther; 1996 Dec; 279(3):1335-44. PubMed ID: 8968358
[TBL] [Abstract][Full Text] [Related]
16. Relationship between agonist-induced muscarinic receptor loss and desensitization of stimulated phosphoinositide turnover in two neuroblastomas: methodological considerations.
Thompson AK; Fisher SK
J Pharmacol Exp Ther; 1990 Feb; 252(2):744-52. PubMed ID: 2156059
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the subtype of muscarinic receptor coupled to the stimulation of phosphoinositide hydrolysis in 132-1N1 human astrocytoma cells.
Stephan CC; Sastry BV
Cell Mol Biol (Noisy-le-grand); 1992 Nov; 38(7):701-12. PubMed ID: 1282058
[TBL] [Abstract][Full Text] [Related]
18. Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors.
Jakubík J; Bacáková L; el-Fakahany EE; Tucek S
J Pharmacol Exp Ther; 1995 Sep; 274(3):1077-83. PubMed ID: 7562472
[TBL] [Abstract][Full Text] [Related]
19. Short-term desensitization of muscarinic cholinergic receptors in mouse neuroblastoma cells: selective loss of agonist low-affinity and pirenzepine high-affinity binding sites.
Cioffi CL; el-Fakahany EE
J Pharmacol Exp Ther; 1986 Sep; 238(3):916-23. PubMed ID: 3018226
[TBL] [Abstract][Full Text] [Related]
20. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Selective loss with subculturing of the low-affinity agonist site mediating cyclic GMP formation.
McKinney M; Stenstrom S; Richelson E
Mol Pharmacol; 1984 Sep; 26(2):156-63. PubMed ID: 6148690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]